Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Milieve (YPS-301BD)

K-Number: K233751 · 2024-06-03

Decision Date2024-06-03
Product CodePCC
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Milieve (YPS-301BD) is the device name listed in this FDA 510(k) record. The listed applicant is Soterix Medical, Inc.. It received FDA 510(k) clearance on 2024-06-03 under 510(k) number K233751. The device is classified under product code PCC. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Milieve (YPS-301BD)?

Milieve (YPS-301BD) is a medical device that received FDA 510(k) clearance on 2024-06-03. The listed applicant is Soterix Medical, Inc.. The 510(k) number is K233751.

When did Milieve (YPS-301BD) receive FDA 510(k) clearance?

Milieve (YPS-301BD) received FDA 510(k) clearance on 2024-06-03, under 510(k) number K233751.

Who is the listed applicant for Milieve (YPS-301BD)?

The FDA 510(k) record lists Soterix Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Milieve (YPS-301BD)?

The FDA product code for Milieve (YPS-301BD) is PCC.

Other records listing Soterix Medical, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: PCC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.